Genital Herpes Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

October 2019 | 70 pages | ID: G032AD66D539EN
VPAResearch

Abstracts

Genital Herpes Drug pipeline report- 2020 is an annual R&D review of Genital Herpes pipeline candidates. The report presents the current status of all major Genital Herpes therapeutic compounds. Detailed insights into Genital Herpes pipeline development, current status, companies, drug profiles and Genital Herpes preclinical and clinical trials are included.

2020 Genital Herpes Pipeline Market Insights
Genital Herpes disease overview, 2020 pipeline review, insights into leading companies, dominant mechanism of action, majority of administration route of Genital Herpes therapies, pipeline by phase and others are included.

Genital Herpes pipeline Drug profiles-
Active and inactive drug profiles covering information including drug name/synonym, sponsor/collaborators/Developer/originator, drug mechanism, route of administration, orphan drug status, NME, phase, development status, and others are included.

Genital Herpes Therapeutic Drug candidates
Both active and inactive Genital Herpes pipeline drug candidates are included in the report

Genital Herpes Clinical Trials and preclinical Studies
Genital Herpes In-vitro and In-vivo studies, discovery stage and pre-clinical stage trial details, Clinical trial titles, duration, location, phase, sponsors, and other details are provided.

Genital Herpes pipeline market developments
Genital Herpes Pipeline market news and deals including mergers, acquisitions, approvals, collaborations, trial initiations, results, investments, licensing opportunities and others are provided.

Genital Herpes pipeline companies in active development
The report analyzes Genital Herpes pipeline of the below companies-

Abivax SA, Admedus Ltd, AiCuris GmbH & Co KG, Auritec Pharmaceuticals Inc, BlueWillow Biologics, Brandenburg Antiinfektiva GmbH, GenVec Inc, Immune Design Corp, Immune System Regulation Holding AB, N & N Pharmaceuticals Inc, NanoViricides Inc, Profectus BioSciences Inc, Rational Vaccines Inc, Redbiotec AG, Sanofi Pasteur SA, SL VaxiGen Inc, Starpharma Holdings Ltd, United BioPharma Inc, Vaccibody AS, Viramatix Sdn Bhd

Report Coverage

What to look out for in 2020
Drugs moving from early stage to mid-to-late stages and drugs to look after in 2020 are included

Pipeline Snapshot
Pipeline candidate count - Drug by phase, mechanism of action, route of administration, designation and others

Companies
20 Companies investing in Genital Herpes pipeline from discovery stage to pre-registration phase are included

Drug profiles
Over 10 details of each Genital Herpes pipeline candidate are included

Company Profiles
Business overview and contact details of all companies operating in the industry are provided

Market Developments
News, Developments and other recent industry developments are included

Contents

1. GENITAL HERPES PIPELINE MARKET INSIGHTS, 2020

1.1 Genital Herpes Disease Overview
1.2 Genital Herpes Drug Pipeline Snapshot, 2020
  1.2.1 Genital Herpes Pipeline Drugs by Phase
  1.2.2 Genital Herpes Pipeline Drugs by Company
  1.2.3 Genital Herpes Pipeline Drugs by Mechanism of Action
  1.2.4 Genital Herpes Pipeline Drugs by Route of Administration

2. GENITAL HERPES COMPANY WISE PIPELINE DETAILS

Abivax SA Genital Herpes Pipeline Drugs
  Company Profile
  Drug Candidate Details
Admedus Ltd Genital Herpes Pipeline Drugs
  Company Profile
  Drug Candidate Details
AiCuris GmbH & Co KG Genital Herpes Pipeline Drugs
  Company Profile
  Drug Candidate Details
Auritec Pharmaceuticals Inc Genital Herpes Pipeline Drugs
  Company Profile
  Drug Candidate Details
BlueWillow Biologics Genital Herpes Pipeline Drugs
  Company Profile
  Drug Candidate Details
Brandenburg Antiinfektiva GmbH Genital Herpes Pipeline Drugs
  Company Profile
  Drug Candidate Details
GenVec Inc Genital Herpes Pipeline Drugs
  Company Profile
  Drug Candidate Details
Immune Design Corp Genital Herpes Pipeline Drugs
  Company Profile
  Drug Candidate Details
Immune System Regulation Holding AB Genital Herpes Pipeline Drugs
  Company Profile
  Drug Candidate Details
N & N Pharmaceuticals Inc Genital Herpes Pipeline Drugs
  Company Profile
  Drug Candidate Details
NanoViricides Inc Genital Herpes Pipeline Drugs
  Company Profile
  Drug Candidate Details
Profectus BioSciences Inc Genital Herpes Pipeline Drugs
  Company Profile
  Drug Candidate Details
Rational Vaccines Inc Genital Herpes Pipeline Drugs
  Company Profile
  Drug Candidate Details
Redbiotec AG Genital Herpes Pipeline Drugs
  Company Profile
  Drug Candidate Details
Sanofi Pasteur SA Genital Herpes Pipeline Drugs
  Company Profile
  Drug Candidate Details
SL VaxiGen Inc Genital Herpes Pipeline Drugs
  Company Profile
  Drug Candidate Details
Starpharma Holdings Ltd Genital Herpes Pipeline Drugs
  Company Profile
  Drug Candidate Details
United BioPharma Inc Genital Herpes Pipeline Drugs
  Company Profile
  Drug Candidate Details
Vaccibody AS Genital Herpes Pipeline Drugs
  Company Profile
  Drug Candidate Details
Viramatix Sdn Bhd Genital Herpes Pipeline Drugs
  Company Profile
  Drug Candidate Details

3. GENITAL HERPES DRUG PIPELINE PROFILES

3.1 Discovery and Preclinical Drug Profiles
3.2 Phase 1 Drug Profiles
3.3 Phase 2 Drug Profiles
3.4 Phase 3 Drug Profiles

4. GENITAL HERPES PIPELINE NEWS AND DEVELOPMENTS

5. APPENDIX

5.1 Primary and Secondary Research Methodology
5.2 Publisher Expertize
5.3 Contacts